42 completed, 17 unknown, 8 active not recruiting, 5 recruiting. 20 Not applicable, 17 Phase 2, 8 Phase 1, 6 Phase 3, 4 Phase 4.
Follow SARS CoV 2 Infection: new trials by email Literature Review of SARS CoV 2 Infection trials Research Report on SARS CoV 2 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections Baseline MxA testing, Serial MxA testing, MxA result feedback and antiviral treatment recommendations - Respiratory Viral Infections, Influenza | Not applicable | Not yet recruiting | Capital Medical University | 618 | 2026-11-30 | 2026-10-23 |
| Clinical Validation of the NowFuture Digital Flu / COVID Test in Anterior Nasal Samples for Over-the-Counter (OTC) Use in Australia Diagnostic test for SARS-CoV-2, influenza A and influenza B - SARS CoV 2 Infection, Influenza A Virus Infection | Not applicable | Active not recruiting | Biocrucible Ltd | 500 | 2026-08-17 | 2026-10-06 |
| Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections SARS CoV 2 Infection, RSV Infections | Not yet recruiting | Fabiana Sherine Ganem dos Santos | 150 | 2026-07-01 | 2026-06-11 | |
| Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS To Measure levels of circulating monocyte/ T cell doublets at Baseline, To measure levels of circulating monocyte/ T cell doublets after 28 days of 2 HOBA treatment, To measure levels of circulating monocyte/ T cell doublets after 28 days of Placebo treatment - Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS) | Phase 2 | Recruiting | Vanderbilt University Medical Center | 50 | 2025-12-18 | 2026-01-22 |
| Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients Remdesivir (RDV) - COVID - 19, Renal Transplant | Phase 2 | Recruiting | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 15 | 2025-09-01 | 2025-09-29 |
| Pancoronavirus Vaccine Study in Healthy Adults CoV-RBD-scNP-001 and 3M-052-AF - COVID-19 Respiratory Infection, SARS CoV 2 Infection | Phase 1 | Terminated | Duke University | 4 | 2025-08-01 | 2026-10-19 |
| Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters Carried Out as Part of the Routine RIPH2 - SARS CoV 2 Infection | Not applicable | Not yet recruiting | CerbaXpert | 7500 | 2024-12-23 | 2024-04-15 |
| CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools Daily Influenza, RSV or SARS-CoV-2 PCR testing for 14 days - SARS CoV 2 Infection, RSV Infection | Active not recruiting | The Hospital for Sick Children | 500 | 2024-10-10 | 2026-05-01 | |
| Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States protein subunit: Novavax COVID-19 vaccine, Pfizer mRNA COVID-19 vaccine - COVID-19, Vaccine-Preventable Diseases | Phase 4 | Completed | Novavax | 660 | 2024-09-19 | 2026-06-02 |
| Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2 IMNN-101 - SARS CoV 2 Infection | Phase 1 / Phase 2 | Completed | Imunon | 24 | 2024-06-04 | 2025-07-23 |
| Development and Validation of (Bio)Sensors for the Identification of Pathogens Nanobiotechnology platforms - Infections, Infection, Bacterial | Completed | University of Bologna | 149 | 2024-05-30 | 2025-12-10 | |
| Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women TURKOVAC - COVID-19, SARS CoV 2 Infection | Phase 2 | Withdrawn | Health Institutes of Turkey | 2024-01-01 | 2025-05-30 | |
| Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection Influenza A Infection, Influenza B Virus Infection | Enrolling by invitation | Karolinska Institutet | 800 | 2024-01-01 | 2024-05-07 | |
| The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection Novavax COVID-19 vaccine (2023-2024 formula XBB containing), Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing) - COVID-19, Vaccine-Preventable Diseases | Phase 4 | Completed | Sarang K. Yoon, DO, MOH | 1188 | 2023-11-22 | 2026-01-28 |
| Eficacia Ventilatoria y Remolacha Remolacha - SARS CoV 2 Infection, Muscle Disorder | Not applicable | Unknown | Hospital de Mataró | 30 | 2023-11-13 | 2024-01-22 |
| Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients Influvac Tetra - Apnea, Obstructive Sleep, SARS CoV 2 Infection | Unknown | Parc Taulí Hospital Universitari | 50 | 2023-11-06 | 2024-04-02 | |
| FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections - Influenza A, Influenza Type B | Unknown | Baebies, Inc. | 2500 | 2023-10-02 | 2023-07-03 | |
| Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects RQ-001, Placebo - COVID-19, Infectious Disease | Phase 1 | Completed | Red Queen Therapeutics, Inc. | 66 | 2023-09-27 | 2024-01-11 |
| A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19 BIMERVAX, SIIV - SARS CoV 2 Infection, Influenza, Human | Phase 2 | Completed | Hipra Scientific, S.L.U | 279 | 2023-09-04 | 2024-02-26 |
| To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M Prolectin-M - COVID-19, SARS CoV 2 Infection | Phase 2 | Unknown | Bioxytran Inc. | 40 | 2023-09-01 | 2023-09-28 |
Showing 20 of 83. Sign in to see all of them.
COVID-19 (83) · Infections (4) · Influenza, Human (4) · Pneumonia (4) · Post-Acute COVID-19 Syndrome (4) · Respiratory Syncytial Virus Infections (4) · Coronavirus Infections (3) · Cognitive Dysfunction (2) · Fatigue (2) · Postural Orthostatic Tachycardia Syndrome (2) · Respiratory Insufficiency (2) · Respiratory Tract Infections (2) · Vaccine-Preventable Diseases (2) · Virus Diseases (2) · Anemia, Sickle Cell (1)
Nidovirales Infections (83) · Coronaviridae Infections (82) · Lung Diseases (82) · Pneumonia, Viral (82) · RNA Virus Infections (82) · Respiratory Tract Diseases (82) · Respiratory Tract Infections (81) · Virus Diseases (81) · Coronavirus Infections (80) · Infections (79) · Pneumonia (79) · Pathological Conditions, Signs and Symptoms (10) · Pathologic Processes (7) · Disease Attributes (6) · Nervous System Diseases (6)
Ad26COVS1 (3) · 2019-nCoV Vaccine mRNA-1273 (2) · BNT162 Vaccine (2) · Diagnostic Tests, Routine (2) · NVX-CoV2373 adjuvated lipid nanoparticle (2) · Blood Specimen Collection (1) · Cetylpyridinium (1) · Chlorpheniramine (1) · EDP-235 (1) · Ethanol (1) · Exercise (1) · HIPRA COVID-19 vaccine (1) · Hyperbaric Oxygenation (1) · Immunity, Humoral (1) · KPNA1 protein, human (1)
Hipra Scientific, S.L.U (3) · Ascletis Pharmaceuticals Co., Ltd. (2) · Centre Hospitalier Régional Metz-Thionville (2) · Columbia University (2) · Fundacin Biomedica Galicia Sur (2) · Novavax (2) · University Magna Graecia (2) · University of Bologna (2) · Vanderbilt University Medical Center (2) · ANRS, Emerging Infectious Diseases (1) · Astana Medical University (1) · Baebies, Inc. (1) · Banaras Hindu University (1) · Belfast Health and Social Care Trust (1) · Biocrucible Ltd (1)
United States (23) · Spain (12) · France (6) · Italy (6) · China (4) · Australia (3) · Turkey (Türkiye) (3) · Denmark (2) · India (2) · Portugal (2) · Tunisia (2) · United Kingdom (2) · Argentina (1) · Belgium (1) · Benin (1)
Cyndya Shibao, M.D (2) · Delivette Castor, PhD (2) · Federico Longhini, MD (2) · Andrea F Grau, Medicine (1) · Andrea Troxel, ScD (1) · Bin Cao, M.D. (1) · Candice Prowse (1) · Castro Miguel, MD (1) · Cecile A Feldman (1) · Clarissa Valim, MD ScD (1)
PMID 20158912, PMID 32865490, PMID 33379178, PMID 34242841, PMID 34554629, PMID 34763723, PMID 34864935, PMID 35526537, PMID 35582123, PMID 36401338, PMID 36435633, PMID 36634692, PMID 36962838, PMID 37106344, PMID 37328890, PMID 37549192, PMID 37730833, PMID 37775521, PMID 38035747, PMID 38278629, PMID 38460525, PMID 38806352, PMID 38956517, PMID 38988285, PMID 39052718, PMID 39269490, PMID 39527880, PMID 39946403, PMID 41592795, PMID 42811742
2023 (1), R01AI164686 (1)